FDA Greenlights Updated COVID-19 Shots for Vulnerable Amid Rising Cases
The U.S. Food and Drug Administration (FDA) gave its nod on Thursday, August 27, 2026, to new, updated COVID-19 vaccines from Pfizer-BioNTech, Moderna, and Novavax-Sanofi. These shots are specifically for people at higher risk of getting very sick, like older adults and those with existing health problems. This decision comes as COVID-19 cases are starting to go up in many parts of the United States, with a new variant spreading more widely.














